1. Home
  2. NECB vs CRDF Comparison

NECB vs CRDF Comparison

Compare NECB & CRDF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NorthEast Community Bancorp Inc.

NECB

NorthEast Community Bancorp Inc.

HOLD

Current Price

$23.39

Market Cap

310.9M

Sector

Finance

ML Signal

HOLD

Logo Cardiff Oncology Inc.

CRDF

Cardiff Oncology Inc.

HOLD

Current Price

$1.57

Market Cap

130.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NECB
CRDF
Founded
1934
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
310.9M
130.7M
IPO Year
2021
2012

Fundamental Metrics

Financial Performance
Metric
NECB
CRDF
Price
$23.39
$1.57
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$9.63
AVG Volume (30 Days)
29.5K
576.4K
Earning Date
04-20-2026
05-07-2026
Dividend Yield
4.21%
N/A
EPS Growth
N/A
27.37
EPS
3.25
N/A
Revenue
N/A
$365,993.00
Revenue This Year
$9.76
N/A
Revenue Next Year
$11.94
N/A
P/E Ratio
$7.30
N/A
Revenue Growth
N/A
49.61
52 Week Low
$19.27
$1.48
52 Week High
$25.18
$4.56

Technical Indicators

Market Signals
Indicator
NECB
CRDF
Relative Strength Index (RSI) 47.37 31.92
Support Level $22.25 $1.51
Resistance Level $24.16 $1.68
Average True Range (ATR) 0.61 0.10
MACD 0.04 -0.02
Stochastic Oscillator 49.28 1.98

Price Performance

Historical Comparison
NECB
CRDF

About NECB NorthEast Community Bancorp Inc.

NorthEast Community Bancorp Inc operates as a community-oriented financial institution. It is principally engaged in the business of attracting deposits and investing those funds into mortgage and commercial loans. It conducts activities throughout the Northeastern United States, including New York, Massachusetts, New Jersey, and Connecticut. The company offers a comprehensive line of banking products and services, including mobile banking as well as commercial real estate loans, commercial construction financing, lines of credit, and term loans. It also offers investment advisory and financial planning services.

About CRDF Cardiff Oncology Inc.

Cardiff Oncology Inc is a clinical-stage biotechnology company that leverages PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies for various cancers with unmet medical needs. The company focuses on targeting tumor vulnerabilities with treatment combinations of onvansertib, its oral and selective PLK1 inhibitor, and standard-of-care (SoC) therapeutics. The firm's clinical program pipeline focuses on indications such as RAS-mutated metastatic colorectal cancer (mCRC), investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma (mPDAC), small cell lung cancer (SCLC), metastatic triple negative breast cancer (mTNBC), and Chronic Myelomonocytic Leukemia (CMML). Geographically, it operates only in the United States.

Share on Social Networks: